← feed

Is NCT03397888 results overdue?

Yes — results are overdue. Primary completion was 2018-01-16; the FDAAA-801 reporting deadline (2019-01-16) passed 2713 days ago and no results are posted on ClinicalTrials.gov.

The Effect o f Hepatic Impairment on the Pharmacokinetics and Pharmacodynamics of Betrixiban, an Oral FXa Antagonist

NCT IDNCT03397888 ↗
SponsorPortola Pharmaceuticals (INDUSTRY)
PhasePHASE1
StatusCOMPLETED
Primary completion2018-01-16 (ACTUAL)
Reporting deadline2019-01-16 (completion + 365d)
Days overdue2713
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 99c3498c1aeff9fd… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03397888. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →